EDNRA and neoplasm: This information is in agreement with our previous observation that in induced colon carcinomatosis in the rat, bosentan, a dual ETA/ETB-receptor antagonist (Clozel et al, 1993), has the potential to reduce initial tumour growth (Peduto-Eberl et al, 2000; Egidy et al, 2000).